Celgene Corp. buy melinda
Start price
11.10.13
/
50%
€56.45
Target price
23.12.13
€60.00
Performance (%)
9.27%
End price
23.12.13
€61.68
Summary
This prediction ended on 23.12.13 with a price of €61.68. The BUY prediction by melinda finished with a performance of 9.27%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Celgene Corp. | - | - | - | - |
| iShares Core DAX® | -1.862% | 0.670% | 0.920% | 51.849% |
| iShares Nasdaq 100 | -3.322% | 4.989% | 33.716% | 86.850% |
| iShares Nikkei 225® | -2.299% | 6.129% | 52.955% | 63.321% |
| iShares S&P 500 | -1.313% | 3.399% | 24.674% | 66.112% |
Comments by melinda for this prediction
In the thread Celgene Corp. diskutieren
erhöhen
RBC Capital Markets